Ligand to Report Third Quarter Results on November 9th

Go back to Ligand to Report Third Quarter Results on November 9th
LIGAND PHARMA (NASDAQ: LGND) Delayed: 296.77 +2.17 (0.74%)
Previous Close $294.60    52 Week High $139.79 
Open $292.47    52 Week Low $82.07 
Day High $298.29    P/E 690.16 
Day Low $292.47    EPS $0.43 
Volume 48,772